Document Type
Article
Publication Date
2-16-2016
Abstract
Accurate and reproducible measurement of blood-brain barrier (BBB) integrity is critical in the assessment of the pathophysiology of the central nervous system disorders and in monitoring therapeutic effects. The widely-used low molecular weight marker [14C]sucrose is non-specific in the absence of chromatographic separation. The purpose of this study was to develop and validate a sensitive and reproducible LC-MS/MS method for the analysis of stable isotopemodified [13C12]sucrose in brain, plasma, and blood to determine BBB permeability to sucrose. After addition of internal standard (IS, [13C6]sucrose), the marker and IS were recovered from diluted rat blood, plasma, and brain homogenate by protein precipitation using acetonitrile. The recovery of the marker and IS was almost quantitative (90-106%) for all three matrices. The recovered samples were directly injected into an isocratic UPLC system with a run time of 6 min. Mass spectrometry was conducted using multiple reaction monitoring in negative mode. The method was linear (r2 ≥ 0.99) in the concentration ranges tested for the diluted blood and plasma (10–1000 ng/mL) and brain homogenate (1-200 ng/mL). The lower limit of quantitation of the assay was 0.5 pg injected on column. The assay was validated (n = 5) based on acceptable intra- and inter-run accuracy and precision values. The method was successfully used for the measurement of serial blood and plasma and terminal brain concentrations of [13C12]sucrose after a single intravenous does (10 mg/kg) of the marker to rats. As expected, the apparent brain uptake clearance values of [13C12]sucrose were low in healthy rats. The method may be useful for determination of the BBB integrity in animal models.
Recommended Citation
Miah MK, Bickel U, Mehvar R. Development and validation of a sensitive UPLC–MS/MS method for the quantitation of [13C]sucrose in rat plasma, blood, and brain: Its application to the measurement of blood-brain barrier permeability. J Chromatogr B. 2016;1015-1016:105-110. doi: 10.1016/j.jchromb.2016.02.017
Copyright
Elsevier
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Included in
Animals Commons, Cardiovascular System Commons, Medicinal-Pharmaceutical Chemistry Commons, Nervous System Commons, Pharmacy and Pharmaceutical Sciences Commons
Comments
NOTICE: this is the author’s version of a work that was accepted for publication in Journal of Chromatography B. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Journal of Chromatography B, volume 1015-1016, in 2016. DOI:10.1016/j.jchromb.2016.02.017
The Creative Commons license below applies only to this version of the article.